4.3 Article

Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men

Journal

FREE RADICAL RESEARCH
Volume 51, Issue 4, Pages 389-396

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10715762.2017.1321745

Keywords

Atherosclerosis; NADPH oxidase; superoxide; coronary artery calcification; oxidative stress

Funding

  1. Foundation for Applied Medical Research
  2. UTE project CIMA
  3. Ministry of Economy and Competitiveness, Madrid, Spain [SAF2010-20367, SAF2013-49088-R]
  4. Ministry of Economy and Competitiveness, Madrid, Spain (Instituto de Salud Carlos III Grant) [RD06/0014/0008]

Ask authors/readers for more resources

Vascular calcification is a common feature in atherosclerosis and associates with cardiovascular events. Oxidative stress may be involved in the pathogenesis of vascular calcification. Previous studies have shown that the phagocytic NADPH oxidase is associated with atherosclerosis. The objective of the present study was to investigate the association between phagocytic NADPH oxidase-mediated superoxide production and coronary artery calcium (CAC). NADPH oxidase-mediated superoxide production was determined by chemiluminescence and CAC by computed tomography in 159 asymptomatic men free of overt clinical atherosclerosis. Multivariate linear regression analyses were used to assess the relationship between CAC and NADPH oxidase-mediated superoxide production. Compared with individuals in the lowest score of CAC (= 0 Agatston units), those in the upper score (> 400 Agatston units) showed higher superoxide production (p < 0.05). In correlation analysis, superoxide production positively (p < 0.01) correlated with CAC, which in multivariate analysis remained significant after adjusting for age, HDL-cholesterol, triglycerides, body mass index, smoking, arterial hypertension and diabetes mellitus. In conclusion, in a population of men without clinically overt atherosclerotic disease, increased NADPH oxidase-mediated superoxide production associated with enhanced CAC. Albeit descriptive, these findings suggest a potential involvement of phagocytic NADPH oxidase-mediated oxidative stress in CAC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis

Gregorio Romero-Gonzalez, Arantxa Gonzalez, Begona Lopez, Susana Ravassa, Javier Diez

Summary: Heart failure is a major cause of morbidity and mortality in chronic kidney disease patients. Myocardial interstitial fibrosis (MIF), resulting from altered collagen turnover, contributes to the development of heart failure. Various mechanisms in different stages of chronic kidney disease may affect fibroblasts and collagen turnover in the heart. Therefore, understanding MIF could lead to the identification of biomarkers and targets for prevention and treatment of heart failure in chronic kidney disease patients.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Urology & Nephrology

From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

Borja Quiroga, Alberto Ortiz, Juan F. Navarro-Gonzalez, Rafael Santamaria, Patricia de Sequera, Javier Diez

Summary: Cardiorenal syndromes refer to disorders of the heart and kidneys that mutually influence each other. Nephrologists need specialized training in cardiology and collaboration with cardiologists to address the challenges posed by these syndromes.

CLINICAL KIDNEY JOURNAL (2023)

Review Peripheral Vascular Disease

Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action

Javier Diez, Javed Butler

Summary: Hypertensive heart disease is a significant cause of heart failure and its prevalence has been increasing despite improvements in hypertension treatment. The prevention of heart failure in patients with hypertensive heart disease is an important unmet medical need. This article proposes a new perspective that focuses on the detection and reversal of histological changes in the hypertensive heart, particularly myocardial interstitial fibrosis.

HYPERTENSION (2023)

Article Cardiac & Cardiovascular Systems

Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial

Luca Monzo, Joao Pedro Ferreira, John G. F. Cleland, Pierpaolo Pellicori, Beatrice Mariottoni, Mark R. Hazebroek, Tim J. Collier, Joe J. Cuthbert, Burkert Pieske, Johannes Petutschnigg, Fozia Z. Ahmed, Nicolas Girerd, Andrew L. Clark, Franco Cosmi, Jan A. Staessen, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: In individuals at risk for heart failure, treatment with spironolactone reduced the risk of hypokalaemia and was not associated with clinically meaningful hyperkalaemia. Factors associated with hyperkalaemia included diabetes mellitus and randomization to spironolactone, while factors associated with hypokalaemia included the use of thiazides, blood urea concentration, and history of hypertension.

ESC HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials

Joao Pedro Ferreirra, John G. Cleland, Nicolas Girerd, Patrick Rossignol, Pierpaolo Pellicori, Franco Cosmi, Beatrice Mariottoni, Arantxa Gonzalez, Javier Diez, Scott D. Solomon, Brian Claggett, Marc A. Pfeffer, Bertram Pitt, Johannes Petutschnigg, Burkert Pieske, Frank Edelmann, Faiez Zannad

Summary: Spironolactone reduces serum concentrations of PICP in patients with HFpEF, indicating its anti-fibrotic effect.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events

Vishal N. Rao, Javier Diez, Finn Gustafsson, Robert J. Mentz, Michele Senni, Ewa A. Jankowska, Johann Bauersachs

Summary: Vericiguat is a recommended therapy for reducing morbidity and mortality in patients with worsening chronic heart failure. However, there are potential barriers to its prescription, such as lack of familiarity among providers and concerns about adverse effects. This review provides an overview of vericiguat therapy, proposes a guidance strategy, and summarizes patient counseling points.

JOURNAL OF CARDIAC FAILURE (2023)

Review Endocrinology & Metabolism

Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines

Robinson Ramirez-Velez, Arantxa Gonzalez, Antonio Garcia-Hermoso, Inigo Latasa Amezqueta, Mikel Izquierdo, Javier Diez

Summary: Exercise intolerance remains a major unmet medical need in patients with heart failure, and skeletal myopathy is considered as the major limiting factor. Recent studies have suggested that circulating myokines synthesized and secreted by skeletal muscle may provide new insights into the pathophysiology and classification of HF-related skeletal myopathy. These myokines may also serve as biomarkers to personalize physical training for patients with HF and exercise intolerance. Furthermore, the production and secretion of myokines in patients with HF may interact with systemic alterations and affect cardiac structure and function, which can influence adverse cardiac remodeling and clinical outcomes in HF patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2023)

Review Hospitality, Leisure, Sport & Tourism

Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Antonio Garcia-Hermoso, Robinson Ramirez-Velez, Javier Diez, Arantxa Gonzalez, Mikel Izquierdo

Summary: This study investigates the effects of exercise training on exerkines in patients with type 2 diabetes mellitus and determines the optimal exercise prescription. The results show that exercise training can induce changes in exerkine levels, with positive effects on glycated hemoglobin, fasting glucose, waist circumference, and body mass. Therefore, exercise training is an important therapeutic approach for patients with type 2 diabetes mellitus.

JOURNAL OF SPORT AND HEALTH SCIENCE (2023)

Article Medicine, Research & Experimental

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

Amy R. Cross, Carlos E. de Andrea, Maria Villalba-Esparza, Manuel F. Landecho, Lucia Cerundolo, Praveen Weeratunga, Rachel E. Etherington, Laura Denney, Graham Ogg, Ling -Pei Ho, Ian S. D. Roberts, Joanna Hester, Paul Klenerman, Ignacio Melero, Stephen N. Sansom, Fadi Issa

Summary: This study used spatial transcriptomics to explore the interactions between different immune and stromal cell populations in COVID-19-affected lung tissue. Through gene expression analysis of well-preserved lung samples from 3 patients, a common immune-cell signaling circuit involving cytotoxic lymphocytes and pro-inflammatory macrophages was identified in areas of severe lung damage. The expression of IFNG by cytotoxic lymphocytes was associated with the induction of chemokines, while TNF superfamily members (BAFF and TRAIL) were consistently upregulated in severely damaged areas. Validation of these findings in additional COVID-19 patient cohorts supports the potential use of this immune-mediated tissue pathology model for future therapeutic strategies.

JCI INSIGHT (2023)

Review Urology & Nephrology

Practical approaches to building up a cardiorenal clinic

Rafael de la Espriella, Marta Cobo Marcos, Claudio Ronco, Debasish Banerjee, Miguel Gonzalez, Jose Luis Gorriz, Borja Quiroga, Maria Jose Soler, Javier Diez, Julio Nunez

Summary: The population of patients with concomitant heart and kidney disease is expected to increase, significantly impacting public health and healthcare utilization. A multidisciplinary team approach aiming to provide coordinated care is crucial for improving patient outcomes and optimizing healthcare resources.

CLINICAL KIDNEY JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.

CIRCULATION-HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Time to reconsider the perception and management of hypertensive heart disease

Javier Diez, Giuseppe M. C. Rosano, Javed Butler

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Editorial Material Urology & Nephrology

Estimation of glomerular filtration rate in cardiorenal patients: a step forward

Borja Quiroga, Javier Diez

Summary: The progressive reduction in estimated glomerular filtration rate (eGFR) resulting in chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease (CVD). Creatinine plus cystatin C-based eGFR and cystatin C-based eGFR can better assess the risk of adverse cardiovascular outcomes. It is suggested to use cystatin C and/or creatinine plus cystatin C-based eGFR for routine clinical practice in cardiorenal patients to accurately stratify cardiovascular risk and evaluate the kidney and cardiovascular protective effects of SGLT2 inhibitors.

CLINICAL KIDNEY JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Long-Term Prognostic Impact of Estimated Glomerular Filtration Rate on Admission in Patients Hospitalized for Acute Heart Failure

Rafael de la Espriella, Jorge Navarro, Anna Mollar, Luis D'Marco, Patricia Palau, Gema Minana, Pau Llacer, Enrique Santas, Raquel Heredia, Miguel Gonzalez, Jose Luis Gorriz, Pau Codina, Javier Diez, Antoni Bayes-Genis, Julio Nunez

Summary: This multicenter study suggests that an eGFR below 30 mL center dot min(-1)center dot 1.73 m(-2) on admission could be an independent predictor for long-term mortality and readmissions in patients with acute heart failure.

CARDIORENAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study

Torben Lange, Soeren J. Backhaus, Bo Eric Beuthner, Rodi Topci, Karl-Rudolf Rigorth, Johannes T. Kowallick, Ruben Evertz, Moritz Schnelle, Susana Ravassa, Javier Diez, Karl Toischer, Tim Seidler, Miriam Puls, Gerd Hasenfuss, Andreas Schuster

Summary: This study aimed to assess myocardial remodeling processes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement using cardiovascular magnetic resonance imaging. The results showed that 1 year after TAVR, myocardial function improved, myocardial volume regressed, and heart failure recovery occurred.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2022)

No Data Available